- Home
- RRR vs TMDX Comparison
RRR vs TMDX Comparison
Compare RRR & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRR
- TMDX
- Stock Information
- Founded
- RRR 1976
- TMDX 1998
- Country
- RRR United States
- TMDX United States
- Employees
- RRR N/A
- TMDX N/A
- Industry
- RRR Hotels/Resorts
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RRR Consumer Discretionary
- TMDX Health Care
- Exchange
- RRR Nasdaq
- TMDX Nasdaq
- Market Cap
- RRR 3.5B
- TMDX 3.9B
- IPO Year
- RRR 2016
- TMDX 2019
- Fundamental
- Price
- RRR $54.26
- TMDX $112.72
- Analyst Decision
- RRR Buy
- TMDX Buy
- Analyst Count
- RRR 13
- TMDX 11
- Target Price
- RRR $61.54
- TMDX $130.73
- AVG Volume (30 Days)
- RRR 1.3M
- TMDX 990.4K
- Earning Date
- RRR 10-28-2025
- TMDX 10-29-2025
- Dividend Yield
- RRR 3.78%
- TMDX N/A
- EPS Growth
- RRR 15.51
- TMDX 170.70
- EPS
- RRR 3.14
- TMDX 2.54
- Revenue
- RRR $1,995,401,000.00
- TMDX $566,354,000.00
- Revenue This Year
- RRR $4.18
- TMDX $38.84
- Revenue Next Year
- RRR $3.27
- TMDX $20.46
- P/E Ratio
- RRR $17.21
- TMDX $44.72
- Revenue Growth
- RRR 4.69
- TMDX 41.20
- 52 Week Low
- RRR $35.09
- TMDX $55.00
- 52 Week High
- RRR $63.60
- TMDX $145.50
- Technical
- Relative Strength Index (RSI)
- RRR 41.75
- TMDX 39.37
- Support Level
- RRR $53.35
- TMDX $111.04
- Resistance Level
- RRR $59.71
- TMDX $116.50
- Average True Range (ATR)
- RRR 1.74
- TMDX 7.23
- MACD
- RRR -0.04
- TMDX -1.82
- Stochastic Oscillator
- RRR 33.59
- TMDX 7.95
About RRR Red Rock Resorts Inc.
Red Rock Resorts Inc along with its subsidiary is a gaming, development and management company that develops and operates strategically-located casino and entertainment properties. Its casino properties are conveniently located throughout the Las Vegas valley and provide its customers a wide variety of entertainment and dining options. The majority of revenue is derived from Casinos.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.